Theravance Biopharma, Inc. (TBPH) Stock Price History
Historical prices from 2014 to 2026
Loading 10-year price history...
Historical Performance
Short-Term Returns
TBPH Stock Price Trajectory (2014–2026)
As of March 2, 2026, Theravance Biopharma, Inc. (TBPH) trades at $18.25, representing a +95.2% return over the past year. The stock has delivered a +0.9% return over five years, reflecting significant long-term value creation.
The stock reached its all-time high of $43.44 on June 26, 2017. From this peak, TBPH has corrected -58.0%, currently trading 23% above its 200-day moving average, indicating continued institutional support.
When compared to Healthcare sector peers UTHR (+57.4% 1Y), ZLAB (-44.5% 1Y), and AMRN (+27.3% 1Y), TBPH has outperformed the peer group average. Compare TBPH vs UTHR →
Historical Price Data
Showing 30 of 2,965 records| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-02-27 | 18.38 | 18.40 | 17.71 | 18.25 | 18 | +0.33% |
| 2026-02-26 | 19.02 | 19.11 | 17.98 | 18.19 | 18 | -4.56% |
| 2026-02-25 | 19.33 | 19.72 | 18.98 | 19.06 | 19 | 0.00% |
| 2026-02-24 | 19.14 | 19.60 | 18.94 | 19.06 | 19 | -1.04% |
| 2026-02-23 | 19.64 | 19.84 | 18.60 | 19.26 | 19 | -2.03% |
| 2026-02-20 | 19.42 | 19.94 | 19.16 | 19.66 | 19 | +1.18% |
| 2026-02-19 | 19.10 | 19.47 | 18.77 | 19.43 | 269K | +1.36% |
| 2026-02-18 | 18.78 | 19.22 | 18.77 | 19.17 | 430K | -3.72% |
| 2026-02-17 | 19.49 | 19.98 | 19.49 | 19.91 | 32K | +1.95% |
| 2026-02-13 | 19.49 | 19.93 | 19.32 | 19.53 | 395K | +0.67% |
| 2026-02-12 | 19.69 | 19.69 | 19.09 | 19.40 | 295K | -0.56% |
| 2026-02-11 | 19.49 | 19.71 | 18.45 | 19.51 | 422K | +0.57% |
| 2026-02-10 | 19.49 | 19.68 | 19.20 | 19.40 | 284K | -0.51% |
| 2026-02-09 | 20.51 | 20.60 | 19.35 | 19.50 | 546K | -4.79% |
| 2026-02-06 | 19.57 | 20.49 | 19.00 | 20.48 | 778K | +4.60% |
| 2026-02-05 | 19.84 | 20.50 | 19.47 | 19.58 | 351K | -2.54% |
| 2026-02-04 | 20.01 | 20.24 | 19.88 | 20.09 | 499K | +0.50% |
| 2026-02-03 | 19.91 | 20.16 | 19.56 | 19.99 | 293K | +0.81% |
| 2026-02-02 | 19.12 | 20.02 | 18.98 | 19.83 | 319K | +4.70% |
| 2026-01-30 | 19.03 | 19.32 | 18.78 | 18.94 | 329K | -1.25% |
| 2026-01-29 | 19.18 | 19.61 | 18.96 | 19.18 | 224K | +0.79% |
| 2026-01-28 | 19.76 | 19.93 | 18.83 | 19.03 | 402K | -3.99% |
| 2026-01-27 | 19.78 | 20.02 | 19.58 | 19.82 | 264K | +0.35% |
| 2026-01-26 | 19.99 | 20.20 | 19.50 | 19.75 | 305K | -2.42% |
| 2026-01-24 | 20.68 | 20.80 | 19.88 | 20.24 | 545K | 0.00% |
| 2026-01-23 | 20.68 | 20.82 | 19.88 | 20.24 | 552K | -2.41% |
| 2026-01-22 | 20.46 | 21.03 | 20.37 | 20.74 | 340K | +1.82% |
| 2026-01-21 | 20.40 | 20.43 | 19.99 | 20.37 | 360K | -0.24% |
| 2026-01-20 | 19.88 | 21.00 | 19.52 | 20.42 | 299K | +2.05% |
| 2026-01-16 | 20.06 | 20.31 | 19.63 | 20.01 | 267K | -0.50% |
See TBPH's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs TBPH Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare TBPH vs AGIO
See how TBPH stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
How has TBPH stock performed recently?
TBPH returned +95.2% over the past year, beating its 5-year annualized CAGR of +0.9%. The stock trades above its 200-day moving average, confirming the uptrend.
What is TBPH's all-time high price?
Theravance Biopharma, Inc. reached $43.44 on 2017-06-26. The 52-week high is $21.03. Current 1-year return of +95.2% places the stock closer to historical peaks.
Where can I download TBPH historical price data?
This page provides TBPH daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2014-2026, downloadable in CSV format.